NCT00414349

Efficacy and Safety of Topical Versus Systemic Treatment in Postherpetic Neuralgia and Diabetic Polyneuropathic Pain

Safety and Efficacy of Lidocaine 5% Medicated Plaster in Comparison to Systemic Treatment in Postherpetic Neuralgia and Diabetic Polyneuropathic Pain.

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 431 (actual)
• Sponsor: Grünenthal GmbH · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to evaluate lidocaine as topical treatment for peripheral neuropathic pain (as stand-alone treatment and in combination with systemic treatment)

Conditions

• Neuropathic Pain

Interventions

Type	Name	Description
DRUG	Topical analgesic	max. 3 plasters per day for PHN patients max. 4 plasters per day for DPN patients
DRUG	oral intake	300 to 600 mg per day taken orally
DRUG	Topical analgesic	3 plasters for PHN patients per day 4 plasters for DPN patients per day

Timeline

• Start date: 2006-12-01
• Primary completion: 2008-01-01
• Completion: 2008-03-01
• First posted: 2006-12-21
• Last updated: 2019-10-09

Locations

1 site across 1 country: United Kingdom